BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 288 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $509,833 | -20.5% | 10,152 | 0.0% | 0.01% | -18.2% |
| Q2 2023 | $641,606 | +40.5% | 10,152 | 0.0% | 0.01% | +37.5% |
| Q1 2023 | $456,738 | +2.7% | 10,152 | 0.0% | 0.01% | -11.1% |
| Q4 2022 | $444,759 | -33.5% | 10,152 | 0.0% | 0.01% | -35.7% |
| Q3 2022 | $669,000 | +30.4% | 10,152 | 0.0% | 0.01% | +27.3% |
| Q2 2022 | $513,000 | -21.0% | 10,152 | 0.0% | 0.01% | -8.3% |
| Q1 2022 | $649,000 | -40.3% | 10,152 | 0.0% | 0.01% | -33.3% |
| Q4 2021 | $1,087,000 | +4.1% | 10,152 | 0.0% | 0.02% | -5.3% |
| Q3 2021 | $1,044,000 | +16.9% | 10,152 | 0.0% | 0.02% | +11.8% |
| Q2 2021 | $893,000 | -9.5% | 10,152 | 0.0% | 0.02% | -15.0% |
| Q1 2021 | $987,000 | -13.3% | 10,152 | 0.0% | 0.02% | -16.7% |
| Q4 2020 | $1,139,000 | +10.2% | 10,152 | -9.0% | 0.02% | 0.0% |
| Q3 2020 | $1,034,000 | +18.9% | 11,152 | 0.0% | 0.02% | +9.1% |
| Q2 2020 | $870,000 | +33.4% | 11,152 | 0.0% | 0.02% | +15.8% |
| Q1 2020 | $652,000 | -27.0% | 11,152 | 0.0% | 0.02% | -9.5% |
| Q4 2019 | $893,000 | +9.0% | 11,152 | 0.0% | 0.02% | 0.0% |
| Q3 2019 | $819,000 | -22.1% | 11,152 | 0.0% | 0.02% | -25.0% |
| Q2 2019 | $1,052,000 | +64.4% | 11,152 | +39.4% | 0.03% | +64.7% |
| Q1 2019 | $640,000 | +48.5% | 8,000 | 0.0% | 0.02% | +30.8% |
| Q4 2018 | $431,000 | -30.9% | 8,000 | 0.0% | 0.01% | -27.8% |
| Q3 2018 | $624,000 | +22.8% | 8,000 | 0.0% | 0.02% | +20.0% |
| Q2 2018 | $508,000 | -30.8% | 8,000 | 0.0% | 0.02% | -34.8% |
| Q1 2018 | $734,000 | +21.7% | 8,000 | 0.0% | 0.02% | +27.8% |
| Q4 2017 | $603,000 | -17.3% | 8,000 | -23.6% | 0.02% | -18.2% |
| Q3 2017 | $729,000 | +15.3% | 10,468 | -16.0% | 0.02% | +15.8% |
| Q2 2017 | $632,000 | +54.1% | 12,468 | +21.5% | 0.02% | +46.2% |
| Q1 2017 | $410,000 | +86.4% | 10,265 | +30.9% | 0.01% | +85.7% |
| Q4 2016 | $220,000 | -5.6% | 7,843 | 0.0% | 0.01% | -12.5% |
| Q3 2016 | $233,000 | – | 7,843 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |